Joseph K. Schachle
Equibles does not estimate personal net worth.
Get an email with a short summary when Opus Genetics, Inc. publishes a filing, an earnings call transcript or a press release.
Get IRD alertsAbout Joseph K. Schachle
Joseph K. Schachle is recorded as COO at Opus Genetics, Inc. (IRD) since November 27, 2023. Opus Genetics, Inc. reported in an 8-K filed November 27, 2023 that Joseph K. Schachle was appointed Chief Operating Officer, effective November 27, 2023. Opus Genetics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Opus Genetics, Inc. includes Dr. George Magrath (CEO and Board Member), George Magrath (CEO and Board Member), George Magrath, M.D., M.B.A., M.S. (CEO and Board Member) and 7 others.
“Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced the appointment of Joseph (Joe) K. Schachle, M.B.A., into the newly created role of Chief Operating Officer, effective today.”
Affiliation history
-
Current
2023-11-27–present
Company network
Leadership on record at Opus Genetics, Inc.
- Dr. George Magrath CEO, Board Member
- George Magrath CEO, Board Member
- George Magrath, M.D., M.B.A., M.S. CEO, Board Member
- Richard Rodgers CEO, Board Member
- Cam Gallagher Chairman, Board Member
- Nirav Jhaveri CFO
- Rob Gagnon CFO
- Robert Gagnon CFO, Chief Accounting Officer
- Joseph Schachle COO
- Amy Rabourn Chief Accounting Officer